Abstract:Stimuli-responsive nanomaterial-based drug delivery systems that are able to actively target the tumor microenvironment, enhance intratumoral accumulation and release drugs at target sites are attractive therapeutic platforms at present. Here, the first approach that uses proteins to construct dynamic-covalent targeting stimuli-responsive cationic albumin nanoclusters for the highly efficient co-delivery of siRNA and DOX in vitro and in vivo has been developed and achieved considerable efficacy in combination therapy for the growth, migration and invasion of cancer. In this study, the critical strategy of 'dynamic-covalent targeting', as previously mentioned, was developed for the active accumulation of drugs at target sites by fabricating a reversible PEG corona using a pH-sensitive borate ester so as to facilitate the formation of a compact complex and the efficient release of siRNA with or from the nanocluster. In addition, after internalization, the nanocluster can dissociate into cationic albumin via intracellular reduction in an acid environment to achieve stimuli-responsive triggered drug release. As a result, the nanocluster for the co-delivery of DOX and VEGF-siRNA exhibits highly efficient capacity for gene silencing and apoptosis-inducing ability and also markedly suppresses the migration and invasion of cancer cells. Most importantly, it displayed significant combination effects against tumor growth with minimal damage to major organs and provides an effective approach for the safe and efficient delivery of multiple cargoes at target sites.

Albumin modified cationic nanocarriers to potentially create a new platform for drug delivery systems.

Protein Nanoparticles Directed Cancer Imaging and Therapy

In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy

Albumin Nanoparticle Encapsulation of Potent Cytotoxic Therapeutics Shows Sustained Drug Release and Alleviates Cancer Drug Toxicity.

Application of Albumin in Nanodrugs for Cancer Therapy

Albumin As a "trojan Horse" for Polymeric Nanoconjugate Transendothelial Transport Across Tumor Vasculatures for Improved Cancer Targeting

Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.

A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform

Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy

Preformed albumin corona, a protective coating for nanoparticles based drug delivery system.

The Effects of Serum Albumin Pre-Adsorption of Nanoparticles on Protein Corona and Membrane Interaction: A Molecular Simulation Study

Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

Design and self-assembly of Albumin Nanoclusters as a Dynamic-covalent Targeting Co-delivery and Stimuli-responsive Controlled Release Platform

Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy

Experimental and theoretical explorations of nanocarriers’ multistep delivery performance for rational design and anticancer prediction

Albumin-binding Prodrugs Via Reversible Iminoboronate Forming Nanoparticles for Cancer Drug Delivery.

Aptamer-functionalized Albumin-Based Nanoparticles for Targeted Drug Delivery

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles

Effect of Albumin Corona Conformation on in Vitro and in Vivo Profiles of Intravenously Administered Nanoparticles.

Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.